- Home
- CRTO vs EYPT Comparison
CRTO vs EYPT Comparison
Compare CRTO & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRTO
- EYPT
- Stock Information
- Founded
- CRTO 2005
- EYPT 1987
- Country
- CRTO France
- EYPT United States
- Employees
- CRTO N/A
- EYPT N/A
- Industry
- CRTO Advertising
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- CRTO Consumer Discretionary
- EYPT Industrials
- Exchange
- CRTO Nasdaq
- EYPT Nasdaq
- Market Cap
- CRTO 1.1B
- EYPT 967.4M
- IPO Year
- CRTO 2013
- EYPT 2005
- Fundamental
- Price
- CRTO $21.40
- EYPT $11.07
- Analyst Decision
- CRTO Buy
- EYPT Strong Buy
- Analyst Count
- CRTO 9
- EYPT 5
- Target Price
- CRTO $38.67
- EYPT $29.60
- AVG Volume (30 Days)
- CRTO 495.1K
- EYPT 1.6M
- Earning Date
- CRTO 10-29-2025
- EYPT 11-05-2025
- Dividend Yield
- CRTO N/A
- EYPT N/A
- EPS Growth
- CRTO 83.79
- EYPT N/A
- EPS
- CRTO 3.00
- EYPT N/A
- Revenue
- CRTO $1,956,800,000.00
- EYPT $42,339,000.00
- Revenue This Year
- CRTO N/A
- EYPT N/A
- Revenue Next Year
- CRTO $1.84
- EYPT N/A
- P/E Ratio
- CRTO $7.15
- EYPT N/A
- Revenue Growth
- CRTO 0.53
- EYPT N/A
- 52 Week Low
- CRTO $19.50
- EYPT $3.91
- 52 Week High
- CRTO $47.27
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- CRTO 48.91
- EYPT 39.62
- Support Level
- CRTO $21.94
- EYPT $9.65
- Resistance Level
- CRTO $23.36
- EYPT $13.32
- Average True Range (ATR)
- CRTO 0.87
- EYPT 0.85
- MACD
- CRTO 0.18
- EYPT -0.10
- Stochastic Oscillator
- CRTO 38.71
- EYPT 38.69
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.